Search

Search Constraints

You searched for: Author/Creator Denduluri, Neelima

Search Results

1. American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations. Issue 10 (October 2017)

2. Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. (January 2017)

3. BRCA1/2 mutations and risk‐reducing bilateral salpingo‐oophorectomy among Latinas: The UPTAKE study. Issue 2 (3rd October 2020)

4. Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Issue 13 (1st May 2021)

5. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2017)

6. Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial. (May 2023)

7. Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy. Issue 1 (December 2017)

8. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update. Issue 6 (20th February 2021)

9. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype. Issue 24 (25th September 2019)

10. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study. Issue 6 (20th December 2019)